| Study to Investigate Safety, Tolerability and Pharmacokinetics of a Single Ascending Dose of AZD1704 (NCT00692042) | AstraZeneca | 2008-03-01 |
| Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients (NCT00660907) | AstraZeneca | 2008-03-01 |
| Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia (NCT00640601) | AstraZeneca | 2008-03-01 |
| Drug Interaction Study Between AZD3355 and Nexium (NCT00684190) | AstraZeneca | 2008-03-01 |
| AZD7325 Multiple Ascending Dose Study (NCT00681915) | AstraZeneca | 2008-03-01 |
| Atacand (Candesartan) Real Life Study (NCT00620178) | AstraZeneca | 2008-03-01 |
| AZD6280 Multiple Ascending Dose Study (NCT00681317) | AstraZeneca | 2008-03-01 |
| Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment (NCT00692133) | AstraZeneca | 2008-03-01 |
| Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study (NCT00670371) | AstraZeneca | 2008-03-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940 (NCT00689780) | AstraZeneca | 2008-03-01 |
| Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2 (NCT00691743) | AstraZeneca | 2008-03-01 |
| Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey (NCT00660712) | AstraZeneca | 2008-03-01 |
| Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940 (NCT00659490) | AstraZeneca | 2008-02-01 |
| Aclidinium/Formoterol Fixed Combination Dose Finding Study (NCT00626522) | AstraZeneca | 2008-02-01 |
| Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305 (NCT00689403) | AstraZeneca | 2008-02-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386 (NCT00690079) | AstraZeneca | 2008-02-01 |
| Candesartan Effect in Second Stage Arterial Hypertension (NCT00621153) | AstraZeneca | 2008-02-01 |
| Quetiapine Extended Release Depression Symptoms (NCT00640562) | AstraZeneca | 2008-02-01 |
| Observational Usage Study of Statins in Primary Care in France (NCT00680082) | AstraZeneca | 2008-02-01 |
| National Survey on Hypertension in Cardiologic Private Practice (NCT00695175) | AstraZeneca | 2008-02-01 |
| Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients (NCT00622323) | AstraZeneca | 2008-02-01 |
| Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients (NCT00621361) | AstraZeneca | 2008-02-01 |
| Study of AZD8931 in Patients With Advanced Solid Malignancies (NCT00637039) | AstraZeneca | 2008-02-01 |
| Breast Cancer Tumor Care Observational Programme (NCT00660244) | AstraZeneca | 2008-02-01 |
| Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280 (NCT00681746) | AstraZeneca | 2008-02-01 |
| A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients (NCT00690287) | AstraZeneca | 2008-02-01 |
| Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325 (NCT00681720) | AstraZeneca | 2008-02-01 |
| Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments (NCT00688675) | AstraZeneca | 2008-02-01 |
| Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease (NCT00558272) | AstraZeneca | 2008-02-01 |
| Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma (NCT00608218) | AstraZeneca | 2008-01-01 |
| An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients (NCT00681759) | AstraZeneca | 2008-01-01 |
| Reflux Esophagitis Phase III Study (Maintenance Treatment) (NCT00634114) | AstraZeneca | 2008-01-01 |
| Schizophrenic Patients Taking Part in Integrated Care Program (NCT00617214) | AstraZeneca | 2008-01-01 |
| Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers (NCT00687232) | AstraZeneca | 2008-01-01 |
| Utilization Patterns of Pulmicort in Real Life Practice (NCT00660569) | AstraZeneca | 2008-01-01 |
| Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia (NCT00576316) | AstraZeneca | 2008-01-01 |
| Study to Investigate Safety and Tolerability of a Single Dose of AZD6482 (NCT00688714) | AstraZeneca | 2008-01-01 |
| A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer (NCT00617669) | AstraZeneca | 2008-01-01 |
| Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly (NCT00585143) | AstraZeneca | 2008-01-01 |
| A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients (NCT00613652) | AstraZeneca | 2008-01-01 |
| A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2) (NCT00637273) | AstraZeneca | 2008-01-01 |
| Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone (NCT00600756) | AstraZeneca | 2008-01-01 |
| Economic Evaluation of Heart Failure Management in Colombian Clinics (NCT01084564) | AstraZeneca | 2008-01-01 |
| A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (NCT00626548) | AstraZeneca | 2008-01-01 |
| AZD9773 Dose Escalation Study (NCT00615017) | AstraZeneca | 2008-01-01 |
| Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) (NCT00577824) | AstraZeneca | 2008-01-01 |
| Depiction of Prostate Cancer Treatment Alternatives in Greece (NCT00733213) | AstraZeneca | 2008-01-01 |
| Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin) (NCT00692146) | AstraZeneca | 2008-01-01 |
| Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season (NCT00688779) | AstraZeneca | 2008-01-01 |
| Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days (NCT00686179) | AstraZeneca | 2008-01-01 |
| Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France (NCT00679640) | AstraZeneca | 2008-01-01 |
| CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy (NCT00635492) | AstraZeneca | 2008-01-01 |
| Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg (NCT00859560) | AstraZeneca | 2008-01-01 |
| Single Ascending Dose Study (SAD) iv Formulation (NCT00688831) | AstraZeneca | 2008-01-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects (NCT00684502) | AstraZeneca | 2008-01-01 |
| Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00629239) | AstraZeneca | 2008-01-01 |
| Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid (NCT00692705) | AstraZeneca | 2008-01-01 |
| Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment (NCT00614939) | AstraZeneca | 2008-01-01 |
| National Survey on Gastroesophageal Reflux Disease (GERD) Patients (NCT00695838) | AstraZeneca | 2008-01-01 |
| Cardiac Electrophysiological Study (NCT00616629) | AstraZeneca | 2008-01-01 |
| Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours (NCT00621725) | AstraZeneca | 2008-01-01 |
| Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD (NCT00634023) | AstraZeneca | 2008-01-01 |
| Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin (NCT00603239) | AstraZeneca | 2008-01-01 |
| CRESTOR Athero Imaging Head to Head IVUS Study (NCT00620542) | AstraZeneca | 2008-01-01 |
| Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects (NCT00686413) | AstraZeneca | 2008-01-01 |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) (NCT00600496) | AstraZeneca | 2007-12-14 |
| Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not (NCT00688532) | AstraZeneca | 2007-12-01 |
| A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma (NCT00585000) | AstraZeneca | 2007-12-01 |
| Effects of Crestor on Inflammation of Atherosclerotic Plaques (NCT00689416) | AstraZeneca | 2007-12-01 |
| Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU (NCT00628862) | AstraZeneca | 2007-12-01 |
| ARIA (Atacand Renoprotection In NephropAthy Pt.) (NCT00573430) | AstraZeneca | 2007-12-01 |
| To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia (NCT00726362) | AstraZeneca | 2007-12-01 |
| 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period (NCT00575588) | AstraZeneca | 2007-12-01 |
| Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients (NCT00695539) | AstraZeneca | 2007-12-01 |
| National Survey on Hypertension at Hospital (NCT00695266) | AstraZeneca | 2007-12-01 |
| Reflux Esophagitis Phase III Study (Initial Treatment) (NCT00633932) | AstraZeneca | 2007-12-01 |
| Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study (NCT00697008) | AstraZeneca | 2007-12-01 |
| A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC) (NCT00600119) | AstraZeneca | 2007-12-01 |
| Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia (NCT00557778) | AstraZeneca | 2007-11-01 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects (NCT00687141) | AstraZeneca | 2007-11-01 |
| Phase I Multiple-Ascending Dose (Japan) (NCT00538174) | AstraZeneca | 2007-11-01 |
| Drug Interaction Study Between AZD3480 and Cytochrome P450 (NCT00692510) | AstraZeneca | 2007-11-01 |
| Drug Interaction With Metformin (NCT00546741) | AstraZeneca | 2007-11-01 |
| A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases (NCT00554229) | AstraZeneca | 2007-11-01 |
| Open Label, Dose Escalation Phase I Study of AZD2281 (NCT00572364) | AstraZeneca | 2007-11-01 |
| Depressive Symptoms in Acute Manic Episode (NCT00690248) | AstraZeneca | 2007-11-01 |
| A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) (NCT00734097) | AstraZeneca | 2007-11-01 |
| Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) (NCT00530699) | AstraZeneca | 2007-11-01 |
| Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma (NCT00573222) | AstraZeneca | 2007-11-01 |
| Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment (NCT00605267) | AstraZeneca | 2007-10-01 |
| What is the Predictive Value of the Reflux Impact Scale (NCT00536328) | AstraZeneca | 2007-10-01 |
| Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer (NCT00595517) | AstraZeneca | 2007-10-01 |
| Quality of Life in Schizophrenic Patients (NCT00597168) | AstraZeneca | 2007-10-01 |
| Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients (NCT00631189) | AstraZeneca | 2007-10-01 |
| Phase 1 Pharmacokinetics of Intravenous Nexium in Children (NCT00474019) | AstraZeneca | 2007-10-01 |
| Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00536107) | AstraZeneca | 2007-10-01 |
| A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin (NCT00528411) | AstraZeneca | 2007-10-01 |
| Regional Observatory on Metabolic Syndrome- LAZIO (NCT00689455) | AstraZeneca | 2007-10-01 |
| Long-term Safety in Atrial Fibrillation Patients (NCT00645853) | AstraZeneca | 2007-10-01 |
| NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler (NCT00557297) | AstraZeneca | 2007-10-01 |